Ligands That Mimic the Tissue Microenvironment of Replicating Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Protect Ex Vivo Patient Cell Samples from the Cytotoxicity of Combined Treatment with Ibrutinib and Venetoclax (ABT-199)
暂无分享,去创建一个
E. Petricoin | Michael E. Williams | T. Bender | Kallesh D Jayappa | C. Portell | Vicki L. Gordon | V. Gordon | M. J. Weber | K. Jayappa